Arvin is an EIR at Atlas and the Chief Medical Officer at Pheon Therapeutics. He was previously the CMO at Mersana in addition to spending over a decade at Bristol Myers Squibb in a variety of leadership roles focused on early and late-stage clinical development of oncology, hematology, and immuno-oncology therapies. Arvin received a B.A. from Rutgers College and M.D. and Ph.D. degrees from Rutgers Robert Wood Johnson Medical School and completed training in internal medicine at Beth Israel Deaconess, Harvard Medical School and in oncology at Memorial Sloan-Kettering Cancer Center.